enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Prostvac - Wikipedia

   en.wikipedia.org/wiki/Prostvac

   PROSTVAC is being developed in partnership with the National Cancer Institute under a formal Cooperative Research and Development Agreement and has been the subject of multiple ongoing and completed clinical studies, including the global Phase 3 PROSPECT study underway in patients with asymptomatic or minimally symptomatic metastatic prostate cancer (mCRPC). [2]

3. STAMPEDE (clinical trial) - Wikipedia

   en.wikipedia.org/wiki/STAMPEDE_(clinical_trial)

   The trial investigates new approaches for men with metastatic and locally advanced prostate cancer. [1] 117 hospitals in the UK and Switzerland are involved with over 10,000 men are expected to take part in the trial. [2] The men are randomly assigned to one of a number of "arms". The primary outcome by which the arms were judged is overall ...

4. Intellia Therapeutics - Wikipedia

   en.wikipedia.org/wiki/Intellia_Therapeutics

   Intellia also has a number of research programs for in vivo and ex vivo therapeutic candidates with potential applications in diseases including cancer, alpha-1 antitrypsin deficiency, and hemophilia. The company is also working on a variety of additional gene editing technologies including base editing and DNA writing. [5] [6]

5. New Gene-Editing Treatments, Explained - AOL

   www.aol.com/news/gene-editing-treatments...

   For premium support please call: 800-290-4726 more ways to reach us

6. Lentiviral vector in gene therapy - Wikipedia

   en.wikipedia.org/wiki/Lentiviral_vector_in_gene...

   With prostate cancer, the lentivirus is transformed by being bound to trastuzumab to attach to androgen-sensitive LNCaP and castration-resistant C4-2 human prostate cancer cell lines. These two cells are primarily responsible for secretion of excess human epidermal growth factor receptor 2 , which is a hormone linked to prostate cancer. By ...

7. FDA considers first CRISPR gene editing treatment that may ...

   www.aol.com/fda-considers-first-crispr-gene...

   The independent committee is helping the FDA think through how it should evaluate a treatment called exa-cel that could potentially cure people of sickle cell disease, a painful and deadly disease ...